Respiratory Muscle Training for Shortness of Breath after COVID-19
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial does not specify that you need to stop taking your current medications. You may continue using them.
What data supports the idea that Respiratory Muscle Training for Shortness of Breath after COVID-19 is an effective treatment?
The available research shows that Respiratory Muscle Training (RMT) is effective for people experiencing shortness of breath after COVID-19. One study found that a home-based RMT program improved quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. Another study showed significant improvements in breathing symptoms and physical performance after a 12-week home-based program. A systematic review found that RMT improved breathing, physical capacity, and quality of life in most studies. These results suggest that RMT can be a helpful and affordable option for those dealing with ongoing breathing issues after COVID-19.12345
What safety data exists for respiratory muscle training for post-COVID-19 dyspnea?
The studies reviewed indicate that respiratory muscle training, including home-based programs, is generally effective in improving pulmonary measures, dyspnea, physical capacity, and quality of life in post-COVID-19 patients. While the focus is on efficacy, the consistent improvements across multiple studies suggest a favorable safety profile, as no adverse events are reported. This includes programs like inspiratory muscle training and expiratory muscle strength training, which have shown significant improvements in symptoms and functional performance.12345
Is the Home-Based Respiratory Muscle Strength Training Program a promising treatment for shortness of breath after COVID-19?
Yes, the Home-Based Respiratory Muscle Strength Training Program is promising for treating shortness of breath after COVID-19. Studies show it improves breathing, physical performance, and quality of life for people with ongoing symptoms after COVID-19. It is also an affordable and effective option that can be done at home.12346
What is the purpose of this trial?
To evaluate the extent to which a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory breathing exercises compared to expiratory breathing exercises alone will help to improve shortness of breath, respiratory symptoms, breathing function, distance walked, and quality of life in those who are experiencing persistent shortness of breath after having had COVID-19. Measurements will take place at the beginning, 6 weeks, and at 12 weeks in the study.
Research Team
Constance Visovsky, PhD
Principal Investigator
University of South Florida
Eligibility Criteria
This trial is for English-speaking individuals who can walk on their own and think clearly. They must have had COVID-19 in the past and now suffer from persistent shortness of breath, which they rate at least a 3 out of 10 with activity or even at rest. People using oxygen or medications can join, but not those who were wheelchair-bound or needed mechanical ventilation during hospitalization.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory muscle strength training exercises
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Home-Based Respiratory Muscle Strength Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor